Product Information
FINGOLIMOD 0.5 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $2.0973 per EA under NDC 00480782056. Its NADAC has been published 127 times since Mar 20, 2024.
FDA first approved this application on Jul 2, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480782056
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FINGOLIMOD HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208008FDA Approved
7/2/2020
TE Code
AB
On Market Since
2/14/2024
Pharmacological Classes
Price Statistics
The NADAC for FINGOLIMOD 0.5 MG CAPSULE has been published 127 times since Mar 20, 2024, and over the history we have for it it has declined 78.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0973 per EA |
|---|---|
| All-time high | $10.0429 (May 15, 2024) |
| All-time low | $2.0973 (Aug 19, 2026) |
| 52-week high | $5.7374 |
| 52-week low | $2.0973 |
| Median price | $5.7008 |
| Average price | $6.5407 |
| Largest weekly change | -27.4% (Jul 22, 2026) |
| Weeks tracked | 127 |
| Tracking since | Mar 20, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FINGOLIMOD 0.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FINGOLIMOD 0.5 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $2.0973 per EA (NDC 00480782056), effective Aug 19, 2026.
How has the price of FINGOLIMOD 0.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FINGOLIMOD 0.5 MG CAPSULE has declined 78.5%. It has been tracked across 127 weekly CMS publications since Mar 20, 2024.
What are the highest and lowest recorded NADAC prices for FINGOLIMOD 0.5 MG CAPSULE?
Since Mar 20, 2024, the NADAC for FINGOLIMOD 0.5 MG CAPSULE has ranged from a low of $2.0973 (Aug 19, 2026) to a high of $10.0429 (May 15, 2024), with a median of $5.7008 per EA.
Are there cheaper alternatives to FINGOLIMOD 0.5 MG CAPSULE?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FINGOLIMOD 0.5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures FINGOLIMOD 0.5 MG CAPSULE?
FINGOLIMOD 0.5 MG CAPSULE (NDC 00480782056) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.